Zydus Lifesciences has informed that it enclosed a copy of press release dated July 17, 2024 titled ‘Zydus announces non-exclusive patent licensing agreement with Takeda for ‘Vault®’ (Vonoprazan) in India’.
The above information is a part of company’s filings submitted to BSE.